Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Original Research

J Res Educ Indian Med . 2014; 20(2): 67-73


CLINICAL EVALUATION OF VANGA BHASMA IN THE MANAGEMENT OF MADHUMEHA (TYPE-2 DIABETES MELLITUS)

B. J. PATGIRI, DARSHAN K. PARMAR, P. K. PRAJAPATI.

Abstract
Introduction: Madhumeha is a Vataja type of Tridoshaja disease. Vanga is used
abundantly in practice of Ayurveda for the treatment of Madhumeha. It is a drug of choice for the
management of Madhumeha (DM-II). Guduchi Ghana ( aqueous extract of Tinospora cordifolia
(Willd.) Miers) of is also having Mehahara effect and old honey is also to be claimed for Mehaghna
properties. Material and methods: In present study total 64 patients were registered. Out of them
in Group A total 32 patients were managed with Vanga Bhasma (250 mg) along with Guduchi
Ghana (250 mg) + Old Honey (3 ml) as Sahapana whereas in Group B, 32 patients were managed
with Guduchi Ghana (250 mg) + Old Honey (3 ml) for 28 days. Observations and Results: Present
study 14%, 28% and 10% of patients markedly improvement, moderate improvement, mildly
improvement were found in Group A respectively. While 2%, 10% and 24% markedly improvement,
moderate improvement, and mildly improvement were found in Group B respectively. Overall
result showed that Vanga Bhasma possesses the antihyperglycemic effect along with its Sahapana
and it doesn’t have hypoglycemic effect. Conclusion: Vanga Bhasma with Sahapana (Guduchi
Ghana) was found moderate anti-hyperglycemic agent in the patients of Madhumeha (Type-2
Diabetes Mellitus)).

Key words: yurvedic treatment; Diabetes mellitus; Guduchi Ghana; Madhumeha; Madhu; Honey; Vanga Bhasma.



Similar Articles

Boosting proteolytic pathways as a treatment against glycation-derived damage in the brain?
Taylor A, Bejarano E
Neural regeneration research. 2022; 17(2): 320-322

Exosome treatment for stroke with diabetic comorbidity.
Venkat P, Chopp M
Neural regeneration research. 2022; 17(2): 315-317

Hyperglycemia in acute ischemic stroke: physiopathological and therapeutic complexity.
Ferrari F, Moretti A, Villa RF
Neural regeneration research. 2022; 17(2): 292-299

Delving into the recent advancements of spinal cord injury treatment: a review of recent progress.
Flack JA, Sharma KD, Xie JY
Neural regeneration research. 2022; 17(2): 283-291

Potential use of lactate for the treatment of neonatal hypoxic-ischemic encephalopathy.
Tassinari ID, de Fraga LS
Neural regeneration research. 2022; 17(4): 788-790


Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Covid-19 Trends and Statistics
ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.



ScopeMed Web Sites